Home » EPIC Archives: OXB

OXB News Archives



[wpw_follow_term_me posttype="post" taxonomy="post_tag" termid="955"][/wpw_follow_term_me]

Oxford BioMedica Eying up long-term value

Hardman & Co

Oxford BioMedica (OXB) is a specialist, advanced therapy, viral-vector biopharma company. It offers vector manufacturing and development services, while developing proprietary drug candidates, with its LentiVector® platform. 2018 saw significant ...

Read Article »

Oxford BioMedica De-leveraging the balance sheet

Hardman & Co

Oxford BioMedica (LON: OXB) is a specialist, advanced therapy, viral-vector biopharma company. It offers vector manufacturing and development services, while developing proprietary drug candidates, with its LentiVector® platform. 2018 saw ...

Read Article »

Partnering strategy delivering profitability

Hardman & Co

Oxford BioMedica (LON:OXB) is a specialist advanced therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, while retaining proprietary drug candidates. OXB will also receive royalties on commercial ...

Read Article »